Pulmonx LUNG is gearing up to announce its quarterly earnings on Wednesday, 2024-10-30. Here's a quick overview of what investors should know before the release.
Analysts are estimating that Pulmonx will report an earnings per share (EPS) of $-0.45.
Anticipation surrounds Pulmonx's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
Historical Earnings Performance
In the previous earnings release, the company beat EPS by $0.03, leading to a 6.08% drop in the share price the following trading session.
Here's a look at Pulmonx's past performance and the resulting price change:
| Quarter | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| EPS Estimate | -0.42 | -0.46 | -0.41 | -0.43 |
| EPS Actual | -0.39 | -0.36 | -0.36 | -0.39 |
| Price Change % | -6.0% | 22.0% | -18.0% | 11.0% |
Pulmonx Share Price Analysis
Shares of Pulmonx were trading at $6.21 as of October 28. Over the last 52-week period, shares are down 28.52%. Given that these returns are generally negative, long-term shareholders are likely unhappy going into this earnings release.
To track all earnings releases for Pulmonx visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
